MOXIFLOXACIN

SynDRA canonical compound SYN0000130 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	TOP2A
Mechanism of action	bacterial DNA gyrase inhibitor
Indication	bronchitis \| intra-abdominal infections \| pneumonia \| sinusitis \| skin infections
Disease area	infectious disease \| otolaryngology \| pulmonary

All known targets

avelox
moxifloxacin hydrochloride
avolex
moxeza
moxifloxacine
moxifloxacin HCl
Moxifloxacine
Moxifloxacino
Avelox iv
Zimoxin
Avelox
Avelox i.v.
MFX
MXF
MXFX
Vigamox
Avalox (TN)
Avelon (TN)
Avelox (TN)
Moxifloxacin [INN:BAN]
Vigamox (TN)
Avelox I.V.
Actira (*Hydrochloride*)
Avelox (*Hydrochloride*)
(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
Avelox IV
U188XYD42P
Izilox
CHEBI:63611
Actira
BAY128039
BAY 128039
moxifloxacinum
RefChem:6043
DTXCID9028465
J01MA14